Agoracom: Small Cap Investment - Zenith Epigenetics

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Back To Forum List View

Two big thank you’s

tada

Nov 24, 2022 01:46PM

Re: Two big thank you’s

jonzobot

Nov 24, 2022 03:49PM

KOO-KOO2

Rank: Treasurer [?]

Points: 10765 [?]

Votes: 39 Score: 2.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: Two big thank you’s

in response to

Two big thank you’s

tada

posted on Nov 24, 2022 04:33PM

tada, I think it's time for management to give ZEN-3694 a name, the same way RVX-208 is now called apabetalone!

Koo

Re: Two big thank you’s

RVXoldtimer

Nov 24, 2022 05:54PM

Re: Two big thank you’s

tada

Nov 24, 2022 07:41PM

Re: Two big thank you’s

RVXoldtimer

Nov 24, 2022 07:53PM

Re: Two big thank you’s

jonzobot

Nov 24, 2022 07:55PM

Re: Two big thank you’s

tada

Nov 24, 2022 08:40PM

Re: Two big thank you’s

abcabusive

Nov 24, 2022 08:53PM

Re: Two big thank you’s

RVXoldtimer

Nov 24, 2022 09:26PM

Re: Two big thank you’s

KOO-KOO2

Nov 25, 2022 07:18AM

Re: Two big thank you’s

jonzobot

Nov 25, 2022 12:40PM

Re: Two big thank you’s

tada

Nov 25, 2022 02:23PM

Reply New Message

Back To Forum List View

Please to post a reply